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New heterocyclic tetracyclic systems were synthesized. Interaction between 3-R-1,2,4-triazin-
5(4H)-ones and cyclic ketones under acidic conditions leads to the formation of zwitterion derivatives
of 5,6,7,8,9,10,11,12-octahydro-[1,2,4]triazino[1,6- f ]phenanthridine and 1,2,3,6,7,8-hexahydro-bi-
cyclopenta[b,d]pyrido[1,2- f ][1,2,4]triazine.
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Introduction
Annelated pyridines are widespread in naturally oc-
curring organic compounds [1], and they have broad
application in pharmaceuticals [2]. The first tricyclic
pyridines, 1,2,3,6,7,8-hexahydrobicyclopenta[b,d]pyr-
idine and 1,2,3,4,7,8,9,10-octahydrophenanthridine
were synthesized by Chichibabin by condensation of
an ammonia and formaldehyde mixture with cyclo-
pentanone and cyclohexanone, respectively [3]. In this
work the possibility of introducing a heterocycle with
a double C=N bond in the reaction instead of an am-
monia and formaldehyde mixture is investigated.
Results and Discussion
It is known that 3-R-1,2,4-triazin-5(4H)-ones show
high reactivity toward C-nucleophiles whereby addi-
tion products are typically obtained [4]. The reaction
of 3-R-1,2,4-triazin-5(4H)-ones 1a – c with cyclic ke-
tones 2a, 2b in acidic media leads to the tetracyclic
compounds 4 – 7 [5] (Scheme 1). These compounds are
the products of condensation of one molecule of 1a – c
with two molecules of the cyclic ketones 2a, 2b. Using
the more active nucleophile 1-cyclopent-1-enyl-pyrrol-
idine (3) instead of the cyclic ketone 2a under the same
conditions leads to the same condensation product 4
(yield: 15%) (Scheme 1). The molecular structure of
compound 5 is shown in Fig. 1.
The distribution of charges in zwitterions 4 – 7 was
assigned on the basis of literature data for pyrido[2,1-
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Fig. 1. ORTEP diagram of the molecular structure of 5 in the
crystal.
f ]-1,2,4-triazinium-4-olates which could be regarded
to have the base structure for the synthesized poly-
cyclic compounds [5].
The proposed reaction mechanism involves the for-
mation of nucleophilic addition product A in the first
stage, with subsequent addition of one more molecule
of cyclic ketone. Compound B is the result of an elim-
ination of a water molecule and oxidation, leading to
products 4 – 7 (Scheme 2).
Conclusion
In this work we demonstrated that 3-R-1,2,4-triazin-
5(4H)-ones can be successfully used as the source of
a C=N component in the condensation reaction with
cyclic ketones to yield tetracyclic pyridine systems.
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Product R n Solvent Yield (%)
4 Ph 1 DMF 30
4 Ph 1 CH2Cl2 16
5 Ph 2 DMF 44
6 4-ClPh 1 DMF 23
7 SCH3 1 DMF 25 Scheme 1.
Scheme 2. Proposed reaction mechanism
for the synthesis of compounds 4 – 7.
Experimental Section
3-R-1,2,4-triazin-5(4H)-ones 1a, 1b [6], 1c [7] were syn-
thesized by known methods, other starting materials are com-
mercially available. 1H and 13C NMR spectra were recorded
on a Bruker DRX-400 spectrometer using TMS as internal
standard. The mass analyzer was a Bruker Daltonics (Bre-
men, Germany) MicrOTOF-Q II mass spectrometer with an
electrospray ionization source, a 6-port divert valve and a sy-
ringe pump kd Scientific with a flow rate of 180 µL h−1.
General procedure for the synthesis of 4 – 7
Trifluoroacetic acid (100 µL) was added to a suspension
of 3-R-1,2,4-triazin-5(4H)-one (200 mg, 1.15 mmol) in 3 mL
of solvent with stirring. To the resulting solution was added
the corresponding cyclic ketone 2a, 2b (or 1-cyclopentenyl-
pyrrolidine (3)) (2.3 mmol). The reaction mixture was stirred
for 7 d in an open flask under ambient conditions. The formed
sediment was filtered off and recrystallized from DMF. The
residual solution after filtration was evaporated, and an addi-
tional quantity of product was isolated with the help of col-
umn chromatography with CHCl3-EtOH (99 : 1) as eluent.
2-Phenyl-1,2,3,6,7,8-hexahydrodicyclopenteno[b,d]pyrido
[1,2-f][1,2,4]triazin-11-ium-4-olate (4)
M. p. > 300 ◦C. – 1H NMR (400 MHz, CDCl3): δ =
2.29 – 2.20 (m, 2H, CH2), 2.41 – 2.31 (m, 2H, CH2), 3.02 (t,
J = 7.7 Hz, 2H, CH2), 3.13 (t, J = 7.6 Hz, 2H, CH2), 3.49
(t, J = 7.6 Hz, 2H, CH2), 3.59 (t, J = 7.7 Hz, 2H, CH2),
7.54 – 7.39 (m, 3H, Ph), 8.26 – 8.28 (m, 2H, Ph). – 13C NMR
(100 MHz, CDCl3): δ = 22.0, 24.5, 30.4, 31.2, 31.4, 34.0,
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127.9, 128.0, 130.0, 130.9, 135.5, 139.2, 142.9, 150.6, 153.0,
162.6, 165.6. – ESI-MS:m/z = 310.1536 (calcd. 310.1527 for
C19H17N3OLi, [M+Li]+).
2-Phenyl-5,6,7,8,9,10,11,12-octahydro[1,2,4]triazino
[1,6-f]phenantridin-13-ium-4-olate (5)
M. p.> 300 ◦C. – 1HNMR (400MHz, CDCl3): δ = 1.74 –
1.85 (m, 4H, 2CH2), 1.88 – 1.94 (m, 2H, CH2), 1.95 – 2.02
(m, 2H, CH2), 2.67 (t, J = 6.1 Hz, 2H, CH2), 2.71 (t, J =
6.2 Hz, 2H, CH2), 3.35 (t, J = 6.2 Hz, 2H, CH2), 3.61 (t,
J = 6.2 Hz, 2H, CH2), 7.38 – 7.46 (m, 3H, Ph), 8.36 – 8.38
(m, 2H, Ph). – 13C NMR (100 MHz, CDCl3): δ = 21.0, 21.3,
21.5, 21.9, 26.3, 27.2, 27.6, 28.8, 128.0, 128.0, 130.8, 132.2,
135.8, 136.3, 143.4, 146.9, 161.5, 166.5. – ESI-MS: m/z =
332.1758 (calcd. 332.1757 for C21H22N3O, [M+H]+).
2-(4-Chlorophenyl)-1,2,3,6,7,8-hexahydrodicyclopenteno-
[b,d]pyrido[1,2-f][1,2,4]triazin-11-ium-4-olate (6)
M. p.> 300 ◦C. – 1HNMR (400MHz, CDCl3): δ = 2.21 –
2.28 (m, 2H, CH2), 2.41 – 2.34 (m, 2H, CH2), 2.94 (t, J =
7.7 Hz, 2H, CH2), 2.95 (t, J = 3.8 Hz, 2H, CH2), 3.07 (t, J =
7.6 Hz, 2H, CH2), 3.47 (t, J = 7.7 Hz, 2H, CH2), 3.70 (t, J =
7.6 Hz, 2H, CH2), 7.34 (d, J = 8.6 Hz, 2H, 4-ClPh), 8.26 (d,
J = 8.6 Hz, 2H, 4-ClPh). – 13C NMR (100 MHz, CDCl3):
δ = 22.1, 24.7, 30.5, 31.3, 31.6, 34.1, 128.2, 129.4, 130.3,
134.1, 137.1, 139.2, 143.2, 150.7, 153.2, 162.0, 165.7. – ESI-
MS: m/z = 338.1059 (calcd. 338.1055 for C19H17ClN3O,
[M+H]+).
2-Methylthio-1,2,3,6,7,8-hexahydrodicyclopenteno-
[b,d]pyrido[1,2-f][1,2,4]triazin-11-ium-4-olate (7)
M. p. = 261 – 262 ◦C. – 1H NMR (400 MHz, CDCl3): δ =
2.19 – 2.27 (m, 2H, CH2), 2.30 – 2.38 (m, 2H, CH2), 2.50
(s, 3H, SCH3), 2.96 (t, J = 7.8 Hz, 2H, CH2), 3.08 (t, J =
7.6 Hz, 2H, CH2), 3.33 (t, J = 7.8 Hz, 2H, CH2), 3.62 (t,
J = 7.6 Hz, 2H, CH2). – 13C NMR (100 MHz, CDCl3): δ =
13.5, 22.1, 24.7, 30.5, 31.2, 31.5, 34.0, 129.4, 139.2, 143.3,
149.4, 152.5, 162.8, 172.3. – ESI-MS:m/z = 274.1009 (calcd.
274.1009 for [C14H16N3OS]+, [M+H]+).
X-Ray structure determination of 5
X-Ray structure analysis including data collection, cell
refinement and data reduction was carried out with an Ox-
ford Diffraction Xcalibur S CCD diffractometer using the
CRYSALISPRO software package [8]. X-Ray data collection
was carried out at 295(2) K with graphite-monochromatized
MoKα radiation (λ = 0.71073 A˚). The structure was solved
with Direct Methods using SHELXS-97 [9] and refined by
full-matrix least-squares procedures on F2 with SHELXL-
97 [9]. Non-H atoms were refined anisotropically, hydro-
gen atoms were placed in idealized positions and were con-
strained to ride on their parent atoms.
Crystal data for 5: C21H21N3O, Mr = 331.41, crystal
size = 0.49 × 0.48 × 0.04 mm3, monoclinic crystal sys-
tem, space group P21/n, a = 8.2604(12), b = 20.9831(18), c =
10.0864(17) A˚, β = 111.360(13)◦ , V = 1628.2(4) A˚3, Z = 4,
ρcalc = 1.35 g cm−3, F(000) = 704, µ = 0.1 mm−1, refls.
measured = 6038, refls. unique = 3216, Rint = 0.0548, refls.
observed [I ≥ 2 σ (I)] = 1385, parameters refined = 226, R1 =
0.0453, wR2 = 0.0638 for I ≥ 2 σ (I), R1 = 0.1272, wR2 =
0.0699 for all data, GoF = 1.003; residual electron density
(min /max): −0.14 / 0.13 e A˚−3. Comment: The low ratio
of observed to unique reflections was caused by the weakly
diffracting crystal due to the small crystal size.
CCDC 777392 contains the supplementary crystallo-
graphic data for this paper. These data can be obtained free
of charge from the Cambridge Crystallographic Data Centre
via www.ccdc.cam.ac.uk/data request/cif.
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